Introduction
============

Progression from a nontransformed normal cell to a malignant cancer cell requires multiple genetic changes that hyperactivate oncogenes while restraining tumor suppressors ([@bib54]). This occurs via two distinct, but not mutually exclusive, mechanisms: the acquisition of genetic mutations, and gene copy number changes.

Genetic mutations arise as a consequence of cells failing to efficiently detect, repair, and/or respond to DNA damage, and may be subtle (e.g., single nucleotide changes) or more complex (e.g., amplifications, deletions, insertions, translocations; [@bib93]). Mutations can arise spontaneously, as a consequence of endogenous genotoxic stress, such as from stalled/collapsing replication forks generated during S phase or reactive oxygen species produced by normal metabolic activity ([@bib119]; [@bib61]; [@bib13]; [@bib18]). However, environmental and/or genetic perturbations that markedly increase DNA damage---and subsequent mutation rates---greatly facilitate oncogenesis. This is best illustrated by the significant predisposition to cancer in familial genetic diseases where components of DNA repair or checkpoint signaling are lost or mutated; examples include hereditary nonpolyposis colorectal cancer syndrome (HNPCC; mutations in *MLH1*, *MSH2*, *MSH6*, or *PMS2*; [@bib119]; [@bib61]), hereditary breast and ovarian cancer syndrome (mutations in *BRCA1* and *BRCA2*; [@bib37]), Fanconi anemia (caused by mutations in any of a number of Fanconi genes important for DNA repair; [@bib91]), and Li-Fraumeni syndrome (mutations in *TP53*; [@bib133]).

Independent of DNA damage and mutation, whole chromosome and segmental aneuploidies can also dramatically alter gene copy number of relevant oncogenes and tumor suppressors. Recent mouse models demonstrate that merely elevating the rates of chromosome missegregation is sufficient to promote tumor development in vivo, at least in part by facilitating loss of heterozygosity of known tumor suppressor genes ([@bib137]; [@bib6]; [@bib5]). A number of cellular defects are known to generate whole chromosome aneuploidy, including atypical mitotic spindle assembly, inefficient chromosome congression, abnormal microtubule dynamics, cohesion and condensation defects, supernumerary centrosomes, and a defective spindle assembly checkpoint ([@bib115]; [@bib25]; [@bib49]; [@bib63]). The common factor among these defects is that they all manifest during mitosis, when chromosomes physically separate. Thus, it is widely accepted that abnormal mitosis can contribute to tumorigenesis via the generation of aneuploidy.

One unresolved question concerns the extent to which abnormal mitosis and DNA damage, the two key promoters of genomic instability, are linked. Although it has been known for some time that DNA damage adversely affects the efficacy of mitosis, the reciprocal possibility---that abnormal mitosis promotes DNA damage---has been largely overlooked in studies of cancer cell biology. However, several recent reports demonstrate that abnormal mitosis alone is sufficient to generate DNA damage. Thus, impaired mitosis may negatively effect genome stability in two ways: not only by causing genome destabilizing whole chromosome aneuploidy, but also by promoting the acquisition of potentially growth-promoting mutations.

The damaging effects of prolonged mitosis
=========================================

In proliferating cells, the phases of the cell cycle exist to accomplish one specific task: to accurately replicate all chromosomes so that they can be efficiently and equally partitioned into two daughter cells during mitosis. Numerous checkpoints have evolved to ensure that mitosis only proceeds when growth conditions are ideal and chromosomes are efficiently replicated and free of damage. This level of quality control takes time, and, generally speaking, proliferating mammalian somatic cells require 12--30 h to properly prepare for division. By contrast, mitosis itself is relatively rapid, typically lasting only 20--60 min, depending on chromosome number and the efficiency of spindle assembly ([@bib139]). It may seem surprising that cells are programed to move so swiftly through mitosis given its importance and the amount of time and energy invested in preparing for the event. This begs the question: Why the rush?

Ironically, the simplest explanation is that mitosis is both destructive and stressful for the dividing cell, and is therefore a process best finished quickly. During mitosis, among other things, the nuclear envelope is torn apart ([@bib44]), the Golgi and ER membrane systems undergo dramatic reorganization ([@bib59]; [@bib107]), vesicle trafficking ceases ([@bib109]), chromosomes condense and transcription is disabled ([@bib125]; [@bib99]), translation is slowed ([@bib99]; [@bib12]), and both the actin and microtubule cytoskeletons are reshaped to facilitate cell rounding and assembly of the bipolar mitotic spindle ([@bib114]; [@bib75]). Such dramatic perturbations to the normal cellular architecture during mitosis cannot be tolerated indefinitely, and we are just beginning to understand the consequences of extending such an abnormal state: the infrastructure of mitotic chromosomes, slowly but surely, begins to break down during prolonged mitosis, ultimately giving rise to DNA breaks.

The first hints that prolonged mitotic arrest might promote DNA damage came from early studies that used microtubule poisons (e.g., nocodazole, colchicine) to arrest cells in mitosis. Such drug-treated cells were unable to satisfy the spindle assembly checkpoint (SAC) and were maintained in mitotic arrest until they either died in mitosis or "slipped" back into interphase without anaphase or cytokinesis, becoming tetraploid ([@bib106]; [@bib78]; [@bib104]; [@bib100]). These tetraploid cells arrested in the subsequent G~1~ phase in a p53-dependent manner that was shown to be a result of DNA damage, though whether the damage occurred during the prolonged mitosis or was a consequence of slippage was unclear ([@bib78]; [@bib104]; [@bib100]). More robust evidence that DNA damage arises during mitosis quickly followed, after both drug as well as genetic treatments were used to prolong mitosis in a variety of cell lines. DNA damage, as identified by detection of the phosphorylated histone variant H2AX (γ-H2AX; [@bib108]), was observed to subtly emerge beginning ∼6 h after mitotic arrest and gradually accumulate with sustained mitosis ([@bib28]). Many groups, using alternative methods to prolong mitosis in a wide variety of cell types, have confirmed the generality of this finding ([@bib131]; [@bib27]; [@bib58]; [@bib98]).

Why prolonged mitotic arrest causes DNA damage remains an open area of investigation, but some mechanisms have recently become apparent. [@bib98] observed that cells arrested in mitosis for an extended period of time (∼16 h) showed outer mitochondrial membrane permeabilization and subtle leakage of cytochrome *c* concomitant with the emergence of DNA damage ([@bib98]). Release of cytochrome *c* into the cytosol is a well-known initiator of apoptosis, and activates a family of cysteine proteases termed caspases (the "executioners" of the cell). Among the numerous protein targets that caspases cleave is ICAD, an inhibitor of the DNase enzyme CAD ([@bib36]; [@bib110]). Cleaved ICAD thus frees CAD, which in turn proceeds to cleave chromosomal DNA, once presumed to be a "point of no return" for cells ([@bib36]; [@bib110]). However, the authors propose that the low levels of cytochrome *c* release induced by prolonged mitosis may trigger only a partial apoptotic response with limited CAD DNase activation and, instead of shearing chromosomes entirely, simply induce limited DNA breaks ([Fig. 1](#fig1){ref-type="fig"}; [@bib98]). This view is supported by the finding that addition of caspase inhibitors significantly reduces the occurrence of γ-H2AX and mitotic cell death during prolonged mitosis, as does suppression of CAD DNase activity by expression of a noncleavable version of ICAD ([@bib98]). Destruction of another caspase target protein during mitosis, Cap-H, also facilitates chromosomal cleavage by CAD. Cap-H is a member of the condensin I complex, which maintains chromosome structure during mitosis. Cleavage of Cap-H by partially activated caspases abolishes the condensin I complex, disrupts the integrity of compacted mitotic chromosomes, and exposes highly accessible decondensed DNA loops to CAD nuclease activity ([@bib77]). This cleavage of Cap-H by caspases is critical for the induction of DNA breaks: expression of a caspase-resistant form of Cap-H protects mitotic chromosome structure during prolonged mitosis, and prevents chromosomal fragmentation ([@bib77]).

![**Prolonged mitosis gives rise to DNA damage through multiple mechanisms.** Prolonged mitosis leads to depletion of many proteins, including anti-apoptotic proteins such as MCL1. This induces a partial caspase activation and destruction of ICAD and CAP-H, which frees the DNase CAD to cleave decondensed loops on chromosomal DNA. In addition, the telomere-protecting protein TRF2 loses its telomeric localization, exposing the linear ends of chromosomes that are recognized as DSBs. Finally, sister chromatid cohesion is gradually lost during prolonged mitosis, and this "cohesion fatigue" promotes premature sister chromatid separation and merotelic attachment. The forces generated by merotelic attachment at kinetochores may combine with preexisting DNA damage at the underlying centromeres to generate arm-level chromosome breaks, an anomaly commonly observed in human cancers.](JCB_201210040_Fig1){#fig1}

Why cells that undergo protracted mitosis exhibit mitochondrial outer membrane permeabilization and cytochrome *c* release remains unknown. At least part of the explanation comes from the fact that anti-apoptotic proteins of the BCL-2 family, such as MCL1 and BCLxl, which antagonize mitochondrial outer membrane permeabilization and cytochrome *c* release, are gradually lost during prolonged mitosis. Several studies have now identified mitotically active E3 ligases, such as APC^Cdc20^ and SCF^FBW7^, which target MCL1 for proteasomal destruction ([@bib56]; [@bib113]; [@bib68]; [@bib89]). Consequently, prolonged mitosis may eventually reduce MCL1 protein to levels that are insufficient to completely suppress mitochondrial permeability. Collectively, these data reinforce the view that cytochrome *c* release and caspase activation do not necessarily ignite an amplifiable "all or nothing" cellular termination program ([@bib47]; [@bib134]; [@bib1]; [@bib73]; [@bib79]); rather, under certain conditions such as prolonged mitosis, subtle activation of components of the apoptotic machinery can lead to DNA damage without a requisite death sentence.

These data also demonstrate that a number of complex factors regulate the susceptibility of cells to acquiring DNA damage during prolonged mitosis, and suggest that some cells may be more prone to such damage than others. As an example, several studies have demonstrated that efficient loading of components of the condensin II complex to chromosomes requires functional pRb, and that pRb loss, or mutations in pRb that abolish its ability to efficiently load condensin II, lead to chromosome condensation and mitotic defects ([@bib84]; [@bib85]). It would be interesting to examine whether the less compact chromosomes that lack condensin II are more susceptible to caspase-induced nuclease activity and DNA breaks during the abnormally prolonged mitosis. Perhaps an increased susceptibility to DNA breaks during mitosis may help explain the finding that pRb mutations, which abolish condensin II loading without disrupting the normal G~1~--S transition, promote tumor formation and aggressiveness in mouse models ([@bib26]).

Additional pathways, which are independent of partial caspase activation, also promote DNA damage during prolonged mitosis. This is best illustrated by the observation that caspase inhibitors are not always sufficient to prevent the onset of DNA damage during abnormal cell division ([@bib28]). One recent study observed that a large portion of DNA damage that stems from prolonged mitosis initially appears at telomeres, suggesting that telomere-capping proteins, which act to suppress the DNA damage response at the truncated ends of linear chromosomes, might become functionally inactivated ([@bib58]). Indeed, TRF2, one such capping component, has been shown to leave the ends of telomeres during prolonged mitosis, even though its overall levels remain unaltered ([Fig. 1](#fig1){ref-type="fig"}). How this comes about is unclear, but it has been postulated that Aurora B kinase directly or indirectly plays a functional role in regulating the delocalization of TRF2 from telomere ends. One possibility is that TRF2 loss from telomeres is due to enhanced Aurora B activity during prolonged mitosis, perhaps because of a gradual loss of the phosphatase activity that opposes Aurora B ([@bib58]). Indeed, declining steady-state levels of unstable proteins may be a major contributing factor to the accumulation of DNA damage during prolonged mitosis, as mitotic cells are transcriptionally silenced and do not demonstrate cap-dependent translation (only IRES-mediated translation of a limited number of proteins persists; [@bib12]). It would be interesting to know if reducing enzymes (e.g., catalases, peroxidases) are one such family of limiting factors. Reducing enzymes convert DNA-damaging reactive oxygen species (ROS), which are produced by mitochondria during normal aerobic respiration, into byproducts that are harmless to the cell. It is tempting to speculate that reducing enzymes may diminish during prolonged mitosis to levels that can no longer adequately neutralize ROS, thus enabling an attack on DNA.

Although a comprehensive understanding of the mechanisms underlying DNA damage remains to be elucidated, prolonged mitosis clearly poses a substantial threat to the genomic stability and viability of daughter cells. Supporting this notion is the remarkable finding that cells may actually have evolved a "clock" to time the duration of mitosis, thereby furnishing a mechanism to identify potentially dangerous cells that took too long to complete division. If mitosis takes even a little longer to complete than normal (for instance, lasting longer than ∼1.5 h) then the resulting daughter cells activate a durable p53-dependent G~1~ arrest that culls them from the proliferating population ([@bib131]).

This observation raises several questions regarding the trigger for p53-dependent G~1~ arrest in daughter cells that are born from just slightly prolonged mitosis. The most likely culprit, DNA damage, does not appear to be responsible for this phenomenon, as no obvious DNA damage can be detected in cells that are arrested in mitosis for such relatively short periods of time, consistent with previous studies which show that γ-H2AX staining is detectable starting only after ∼5--16 h of mitosis depending on cell type ([@bib28]; [@bib98]). Alternatively, it has been postulated that p53 gradually accumulates during prolonged mitosis, enforcing subsequent arrest in G~1~ ([@bib10]); however, this has not yet been experimentally observed ([@bib90]; [@bib98]). Nevertheless, whatever the stress from prolonged mitosis may be, it appears to persist, or perhaps even permanently mark cells as being defective. This was demonstrated in an elegant experiment in which daughter cells generated from a slightly prolonged mitosis, which would normally arrest, were treated transiently with a p38 inhibitor to allow them to bypass the p53-induced arrest, proceed through a second cell cycle, and reenter mitosis. Remarkably, despite the fact that the second mitosis completed with normal timing, the daughter cells once again rearrested in G~1~ ([@bib131]). This confirms that when it comes to prolonged mitosis, nontransformed cells don't take any chances: strong anti-proliferative mechanisms prevent the progeny of these abnormal cells, and whatever genetic anomalies they may harbor, from further division.

Effects of merotely on genome stability
=======================================

In addition to prolonged mitosis, other aspects of abnormal cell division may play significant roles in generating DNA damage. Recent sequencing efforts have revealed that tumor cells are highly enriched in chromosome whole-arm amplifications, indicative of chromosome breaks at centromeres, yet the mechanisms through which these breaks occur remain completely unresolved ([@bib9]). One distinct possibility is that DNA replication and/or repair mechanisms are inefficient through the highly repetitive α-satellite regions of centromeres, which predisposes to breakage. However, it is also plausible that such shearing events occur during abnormal mitosis as a consequence of merotelic attachments.

Merotelic attachments are a specific type of kinetochore--microtubule attachment error that occurs when a single kinetochore from one chromosome is attached to microtubules from more than one spindle pole ([@bib111]; [@bib19]; [@bib52]). This type of attachment error is particularly dangerous because it satisfies the spindle assembly checkpoint and permits anaphase, even if left uncorrected ([@bib21]). As a consequence, during anaphase the merotelically attached chromosome is simultaneously pulled toward opposite poles via its lone kinetochore. In most cases, one spindle pole has more microtubules attached to the kinetochore than the other, causing segregation of the offending chromosome to one daughter cell, albeit to the same one as its sister chromosome at some low frequency ([@bib21], [@bib22], [@bib23], [@bib24]; [@bib129]). Occasionally, however, both poles pull the single kinetochore with equal strength, thus stalling the progression of the chromosome to one daughter or another. This gives rise to what is referred to as an anaphase "lagging chromosome" ([Fig. 2 A](#fig2){ref-type="fig"}), not to be confused with bridging chromosomes, which are formed by distinct mechanisms (discussed in the next section). Lagging chromosomes can end up in either daughter cell, depending on where the cytokinetic furrow ingresses, though they most frequently segregate to the correct cell, which is the cell opposite to where the sister chromosome segregated ([@bib24]; [@bib129]). Nevertheless, anaphase lagging chromosomes often lag so severely behind the other chromosomes that upon telophase they form their own nuclear envelope, creating a micronucleus, which has its own repercussions (discussed later).

![**Anaphase lagging chromosomes versus chromosome bridges.** (A) Anaphase lagging chromosomes ("Lagging", white arrow) are identified as single, kinetochore-positive chromosomes that lag between the two masses of segregating chromosomes during anaphase. Lagging chromosomes are commonly caused by merotelic attachments. By contrast, pathological chromosome bridges ("Bridging", white arrow) completely span the segregating masses of chromosomes during anaphase. Pathological bridges are caused by condensation and cohesion defects, or by dicentric chromosomes being pulled to opposite poles, and are readily visualized with DNA-intercalating dyes (kinetochores, red; chromosomes stained with the DNA intercalating dye Hoechst, green). Images reproduced from [@bib42]. (B) Ultra-fine chromosome bridges (white arrow) result from inefficient decatenation of sister chromosomes and cannot be detected using DNA dyes, requiring instead detection with specific protein markers (PICH, red; chromosomes stained with the DNA intercalating dye Hoechst, white). Bar, 10 µm. Images courtesy of Taruho Kuroda (Harvard Medical School, Boston, MA).](JCB_201210040_Fig2){#fig2}

Anaphase lagging chromosomes experience a microtubule-generated pulling force that is strong enough to lead to the dramatic physical stretching and deformation of their kinetochores and underlying centromeric DNA ([@bib21], [@bib24]), though whether this force is capable of physically breaking the DNA at the centromere remains unresolved. Consideration of the force required to break the phosphodiester backbone of naked DNA makes the idea somewhat plausible: the estimated force required to rupture a single covalent bond (∼2 nN; [@bib51]) is in the ballpark of a generous estimate of force produced by a mature kinetochore fiber containing ∼20 microtubules (∼0.2--1.5 nN; [@bib3]; [@bib95]). However, arguing against this idea is the fact that breaking highly condensed chromosomal DNA requires a force (∼100 nN) that is 2--3 orders of magnitude stronger than what is produced by a kinetochore fiber ([@bib66]). This is due in part to the high elasticity of chromosomes, which can return to their normal shape after being stretched more than 10 times, and the force-diffusing pliability of kinetochores ([@bib66]; [@bib32]; [@bib83]; [@bib11]). Practically, it also seems illogical that microtubule-generated forces that evolved to push and pull chromosomes in order to facilitate congression and segregation during mitosis would exhibit forces anywhere near strong enough to actually break the chromosomes. Supporting this view, several groups have shown that experimentally induced merotelically attached lagging chromosomes at early anaphase do not display any obvious signs of DNA damage ([@bib128]; [@bib131]; [@bib27]).

Nevertheless, the possibility that certain perturbations may predispose cells to centromere breakage in conjunction with merotely during mitosis cannot be discounted. Evidence for one such situation comes from observations on a mouse cell line that lacks the *Dido* gene product. Dido is a centrosome-localized protein whose loss gives rise to multiple mitotic defects including centrosome amplification and lagging chromosomes ([@bib130]). *Dido*-null cells reportedly exhibit γ-H2AX foci adjacent to merotelically attached kinetochores, which suggests that forces from merotelic attachments may generate sufficient force to break centromeric DNA, at least in certain genetic contexts ([@bib53]).

That cells with preexisting DNA damage are more susceptible to the pulling forces generated by merotelic attachment should also be considered. For example, merotelic attachment may unravel DNA from single-strand nicks, thus promoting conversion to a double-stranded break (DSB). If so, then conditions that promote both DNA damage and merotely might combine to generate breaks specifically at centromeres. One such condition arises during prolonged mitosis: as detailed extensively already, DNA damage accumulates during abnormally protracted mitosis, but occurring concurrently is the gradual loss of cohesion between sister centromeres, a phenomenon termed cohesion fatigue ([@bib29]). A consequence of cohesion fatigue is the disassociation of sister chromatids, which promotes merotelic attachment ([Fig. 1](#fig1){ref-type="fig"}). Thus, it is tempting to speculate that subtle, perhaps imperceptible, DNA damage caused by prolonged mitosis (e.g., single nicks not identified by γ-H2AX localization) may synergize with excess merotely generated after cohesion fatigue or other mitotic defects to promote chromosomes breaks at centromeres.

Rather than breaking chromosomes directly, merotelic attachments could also facilitate the physical separation of chromosomes that already possess breaks at or near centromeres. For example, the MRN complex (Mre11--Rad50--Nbs1), which is a primary responder to DNA DSBs, detects and binds DSBs during mitosis. Mre11 is a component of the MRN complex that is believed to physically tether broken ends of chromosomes, keeping them in close proximity to facilitate repair ([@bib17]; [@bib65]). This raises the possibility that the forces generated by merotelic attachment are sufficient to overcome the tethering forces applied by the MRN complex on broken chromosomes, thus making preexisting DSBs located at or near centromeres significantly more susceptible to being completely torn apart by strong microtubule-generated forces.

The acquisition of DNA damage during cytokinesis
================================================

Cells experiencing abnormal mitosis that progress from prometaphase to anaphase without acquiring DNA lesions are not "out of the woods," especially if they encounter problems in efficiently segregating their chromosomes. Awaiting cells after anaphase is cytokinesis, where a contracting actin-myosin ring, which generates sufficient force to cleave one cell into two, looms. A number of studies in budding and fission yeast, as well as in plants, have established that failure to clear chromosomes from the central spindle and out of the oncoming path of the cytokinetic ring and enclosing cell wall results in chromosomal cleavage, which has dire consequences for cells ([@bib86]; [@bib60]; [@bib8]). Consequently, in yeast a quality control mechanism termed the "NoCut" pathway has been proposed that delays cytokinesis when chromatin fails to segregate out of the spindle midzone---this mechanism buys additional time for resolving the defect ([@bib97]; [@bib87]).

In contrast to the findings in yeast and plants, the consequences of having chromatin trapped within the cleavage plane during the ingression of the cytokinetic furrow is much more variable in mammals, and can give rise to several distinct fates including cleavage furrow regression, abscission delay, and/or chromatin cleavage ([Fig. 3 A](#fig3){ref-type="fig"}). Cleavage furrow regression is a well-documented consequence of having chromatin trapped under the furrow during mammalian cytokinesis ([@bib92]), and in contrast to the obligatory chromosome breakage experienced by yeast, frequently occurs without any visible signs of DNA damage ([@bib120]). This may be due to the fact that mammalian cytokinesis, unlike yeast and plants, does not require potentially damaging cell wall deposition after actin-myosin ring contractility. However, inducing tetraploidy to prevent chromosomal breaks may not be a positive long-term strategy for cells: tetraploid cells possess inherent stresses that typically limit their long-term proliferation ([@bib4]; [@bib40]; [@bib74]), but they also have an increased capacity to promote transformed growth ([@bib34]; [@bib39]; [@bib41]; [@bib30], [@bib31]).

![**Consequences of chromosome bridges.** (A) Chromosome bridges can promote cytokinetic furrow regression, chromosomal cleavage, or abscission failure. However, the factors governing which of these outcomes will occur remain entirely unknown. One possibility is that previously nicked or otherwise damaged chromosomes may be more susceptible to cleavage, whereas undamaged whole chromosomes may be more likely to promote furrow regression or abscission delays. (B) Chromosome bridges (white arrow) that are not cleaved or resolved during cytokinesis persist well into the following cell cycle, even stretching extensively as cells move apart (DNA, white; LAP2, red). Bars, 10 µm. Images courtesy of Taruho Kuroda (Harvard Medical School, Boston, MA).](JCB_201210040_Fig3){#fig3}

Alternatively, it has been reported that an Aurora B--dependent mechanism similar to the yeast NoCut pathway exists in mammalian cells to stabilize the cytokinetic bridge after furrow ingression and prevent abscission in the presence of trapped chromatin ([@bib120]). This pathway potentially provides time for cells to resolve segregation errors during the subsequent interphase while preventing the deleterious effects of tetraploidy. Remarkably, despite the fact that the daughters in this condition remain physically linked by the bridging chromatin, they behave as two discrete entities with independent cell cycle dynamics ([@bib120]). However, virtually nothing is known about how these cells mechanistically resolve the stabilized chromatin that links them, or whether this can be accomplished without chromosomal cutting. Furthermore, chromosome bridges can persist throughout the ensuing cell cycle, and even stretch extensively as cells move far apart ([Fig. 3 B](#fig3){ref-type="fig"}), raising the possibility that no specific mechanisms exist to accurately resolve such bridges once they have been stabilized.

Finally, imaging of mammalian cells confirms that chromatin trapped in the spindle midzone does occasionally break during cytokinesis in mammalian cells ([@bib62]; [@bib112]; [@bib69]), producing recombinagenic fragments that can generate chromosome translocations in the next cell cycle ([@bib69]). Inhibition of cytokinetic ring furrowing can rescue such chromatin from acquiring DNA damage, supporting the idea that cytokinesis plays a direct role in breaking chromosomes ([@bib69]).

What remains entirely unclear are the molecular underpinnings dictating whether or not the trapped chromatin will break or cause furrow regression. A potential source of variability certainly derives from the nature of the trapped chromatin, which can be in the form of a pathological chromosome bridge, an ultra-fine chromosome bridge, or an anaphase lagging chromosome. Pathological chromosome bridges frequently result from dicentric chromosomes, which originate from inappropriately repaired DSBs or from fusions of critically shortened telomeres regions, which are then pulled to opposing poles during anaphase ([Figs. 2 A](#fig2){ref-type="fig"} and [3 A](#fig3){ref-type="fig"}). Condensation and cohesion defects also promote these bridges, which are readily identifiable with common DNA intercalating dyes ([@bib57]; [@bib59]). Ultra-fine chromosome bridges (UFBs), by contrast, are so subtle as to be virtually invisible using standard chromosome staining protocols; they arise from incomplete decatenation of entangled DNA, frequently at centromeres ([@bib14]), and can only be detected by visualizing protein components such as the nuclear membrane protein LAP2 or the helicases PICH and BLM that specifically localize to these bridges ([Fig. 2 B](#fig2){ref-type="fig"}; [@bib7]; [@bib15]; [@bib72]). Unlike pathological bridges, UFBs may play an important structural role in normal mitosis by physically linking sister centromeres during early anaphase in order to maintain tension and prevent SAC reactivation, then resolved in a regulated manner later in anaphase to prevent bridging in the spindle midzone ([@bib7]; [@bib14]). However, such resolution is often deregulated in cancer cells and can give rise to numerous stable UFBs that stem from both centromeres as well as from chromosome arms, after mitosis ([@bib16]). Both pathological and ultra-fine chromosome bridges physically span the entire midzone, and cannot avoid the cytokinetic ring: this makes them fundamentally different from anaphase lagging chromosomes, which are capable of "sidestepping" the ingressing furrow. Bridged chromosomes are therefore significantly more likely to undergo cytokinesis-induced damage, or cause furrow regression, though anaphase lagging chromosomes are not immune ([@bib69]).

Whether or not the cytokinetic furrow cleaves the bridged chromosomes may also reflect whether or not the trapped DNA possesses any additional damage. Bridged chromosomes, weakened by DNA lesions, may be prone to breakage by the combined forces of the anaphase spindle and the cytokinetic ring, whereas undamaged chromosomes may be more resistant, and promote furrow regression. Chromosome bridges may also avoid breakage by finding strength in their numbers: because of their physical properties, chromosome bridges align parallel to the anaphase spindle during cytokinesis, and if more than one chromosome bridge exists in a given cell then the pinching cleavage furrow stacks the separate bridges upon one another. This raises the possibility that a single bridging chromosome is more susceptible to breakage than multiple bridged chromosomes, which may together form a chromatin bundle that is better able to fend off the ingressing furrow.

Imaging studies document that when breakage of bridging chromosomes occurs during cytokinesis, it frequently does so adjacent to centromeres ([@bib62]). Although this may be a direct consequence of centromeres experiencing more pulling forces at anaphase, it is also tempting to speculate that cleavage may be the consequence of a more biochemical reaction, such as nuclease-mediated chromosomal cutting. In this light, it is interesting to note that topoisomerase-IIα, an enzyme important for decatenating sister chromatids, localizes to centromeres during mitosis ([@bib118]; [@bib135], [@bib136]). This raises the possibility that centromere-localized topoisomerase-IIα, or perhaps another cellular nuclease, may play a key role in resolving chromosome bridges by inducing breakage at centromeres.

The cellular response to DNA damage acquired during mitosis
===========================================================

Cells rapidly respond to DNA damage acquired during interphase by engaging signaling pathways that disable cell cycle progression and promote DNA repair ([@bib18]). In contrast, mitotic cells do not activate any checkpoints in response to DNA damage, per se, as studies using laser irradiation or drug treatments to induce minor DNA damage during mitosis show no delays in mitotic progression despite the presence of obvious DNA fragments ([@bib103]). Robust DNA damage can delay mitotic progression, but this only happens when massive damage occurs right at centromeric DNA and alters kinetochore function, thus preventing normal spindle assembly checkpoint silencing ([@bib88]; [@bib96]; [@bib33]).

The discovery that no DNA damage checkpoint exists to delay mitotic progression led to speculation that cells might be "blind" to mitotic chromosomal damage and might fail to mount any sort of response, let alone try and repair the lesions. However, the mere fact that γ-H2AX appears at sites of DNA damage in mitotic cells demonstrates the existence of at least a partial response, as γ-H2AX requires phosphorylation by the kinase ATM, which is recruited to sites of DNA damage by the DNA break-sensing MRN complex ([@bib18]; [@bib45]). Although it is clear that mitotic cells are capable of mounting such a primary DNA damage response, [@bib46] demonstrate that the second phase of the DNA damage response, the recruitment of downstream proteins important for chromosome unwinding and subsequent repair (such as RNF8, RNF168, 53BP1, and BRCA1), is absent until cells exit from mitosis into the subsequent G~1~ phase. Several groups have observed that many of these proteins (e.g., 53BP1), which localize to spontaneously arising DNA breaks during interphase, are removed from chromosomes once cells enter mitosis ([@bib71]; [@bib94]; [@bib132]).

Other aspects of the DNA damage response are similarly impaired during mitosis. For example, the checkpoint kinase Chk2, which is a downstream target of ATM, fails to become activated during mitosis despite the presence of active ATM. This is due at least in part to inhibitory phosphorylation by the mitotically active kinase Plk1 ([@bib132]). Thus, mitotic cells have developed numerous mechanisms to prevent a complete DNA damage response during cell division. It has been speculated that attempting DNA repair in mitosis would be catastrophic, as repair would require disruption of the integrity of the highly compacted chromosome structure and perhaps lead to a multitude of segregation defects, not to mention potentially prolonging stressful mitosis and increasing the risk of acquiring even more damage ([@bib45]). Consequently, it has been posited that mitotic cells simply mark sites of DNA damage during mitosis so that these sites can be more quickly identified and dealt with during the subsequent G~1~ phase, when repair is less threatening ([@bib46]). This still represents a risky proposition, as unrepaired chromosome fragments may ultimately get missegregated during the next mitosis.

Indirect consequences of abnormal mitosis
=========================================

In addition to the direct damage to chromosomal integrity, abnormal mitosis also exerts indirect effects on the future stability of the genome. For example, chromosome missegregation and the generation of aneuploidy are common byproducts of abnormal mitosis and may occur without any immediate acquisition of DNA damage. Nevertheless, aneuploidy is not without consequences: missegregation of even a single chromosome in mammalian cells can lead to the deregulated expression of hundreds, or even thousands, of individual genes, including many that are involved in critical processes such as DNA replication and repair ([@bib138]; [@bib122]). Consequently, it has been observed that spontaneously arising nontransformed aneuploid cells are prone to p53-mediated cell cycle arrest ([@bib128]). However, cells capable of escaping this arrest are subject to increased mutation rates, recombination frequencies, and further chromosome missegregation ([@bib128]; [@bib116]), supporting the long-standing belief that aneuploidy imparts a "mutator phenotype" ([@bib35]; [@bib64]). Thus, missegregation of a single chromosome caused by abnormal mitosis has the capacity to set in motion a self-propagating storm of genomic instability.

Another outcome of abnormal mitosis is the generation of micronuclei, which form when anaphase lagging chromosomes reassemble nuclear envelopes independent from the spatially separated primary nucleus during telophase. Micronuclei are conspicuous structures that have long been observed in genomically unstable tumor cells, yet their biological consequences were controversial ([@bib126]). It has recently been demonstrated that micronuclei possess a lower density of nuclear pores relative to primary nuclei, and exhibit inefficient nuclear import; as a consequence, recruitment of DNA licensing, replication, and repair factors is impaired, and duplication of chromosomes residing in micronuclei during S phase is markedly perturbed, thereby inducing replication stress and DNA breaks ([@bib27]). Furthermore, DNA replication in micronuclei is also asynchronous with primary nuclei, with replication in micronuclei persisting in otherwise G~2~ cells. Upon mitotic entry, chromosomes in micronuclei condense even though they are still in S phase, a phenomenon termed premature chromosome compaction (PCC), which drastically disrupts the normal structural integrity of chromosomes and gives rise to a "pulverized" appearance ([@bib70]; [@bib27]). The extent to which pulverized chromosomes are broken remains unclear, as studies suggest that prematurely compacted chromosomes from normal S phase cells often have thin, unreplicated double-stranded DNA connecting regions of condensed, replicated chromosome masses ([@bib55]; [@bib48]; [@bib50]). However, PCC may have a significantly more detrimental effect on the massively damaged chromosomes in micronuclei, which lack a normal complement of DNA replication and repair machinery. In addition, micronuclei often persist for several cell cycles before reincorporating into the primary nucleus, providing multiple opportunities for chromosomal damage to occur and accumulate.

The isolation of a single chromosome within a micronuclei offers an appealing mechanistic explanation for "chromothripsis," the recently discovered phenomenon in which a massively reorganized whole chromosome, or arm-level chromosome, is generated in a single catastrophic event ([@bib121]). It appears that one mechanism, or a combination of two distinct mechanisms, generate chromothripsis: chromosome pulverization followed by restitching via nonhomologous end-joining, and abortive replication with fork stalling and template switching or microhomology-mediated break induced repair ([@bib81], [@bib82]; [@bib121]; [@bib38]). Both types of defect can occur in micronuclei because chromosomes trapped in micronuclei are prone to both replication stress and fragmentation. Thus, chromothripsis may be another mutagenic outcome of abnormal mitosis.

Conclusions
===========

At any given moment, an estimated 100 million cells in our bodies are undergoing mitosis ([@bib2]). Given the overall complexity and large number of proteins required to successfully accomplish cell division, it is not surprising that the process is not foolproof: roughly 1 out of every 100 cell divisions gives rise to a chromosome missegregation event, indicating an underlying mitotic abnormality ([@bib20]; [@bib127]). Mitotic defects can lead to aneuploidy as well as DNA damage, either of which can severely alter the genetic landscape of a cell and impart strong growth-promoting properties. Thus, both genetic and environmental factors that disrupt mitosis may play a more significant role in generating tumorigenesis than previously appreciated.

Nevertheless, it is interesting to consider whether exploiting the consequences of abnormal mitosis may have therapeutic value, especially given that such events preferentially occur in tumor, and not normal, cells. As an example, two common byproducts of abnormal mitosis---extra centrosomes and aneuploidy---have been identified as potentially cancer-specific drug targets ([@bib102]; [@bib76]; [@bib80]; [@bib124]; [@bib101]). Other defects arising from chaotic mitosis, such as tetraploidy, micronuclei, and bridging chromosomes, also represent potential therapeutic targets.

Moreover, a detailed understanding of how cells respond to DNA damage during mitosis may also help to improve existing anti-mitotic therapies that target rapidly dividing mitotic cells (e.g., Taxol). Although this class of drugs has proven beneficial, and often even curative, many cancers remain refractory. This is due in large part to the fact that cells are capable of escaping mitosis through slippage before a full apoptotic response can be achieved ([@bib43]). Consequently, it has recently been proposed that targeting mitotic exit, and thus forcing cells to persist in a state of stressful and damaging mitosis, may have a stronger therapeutic effect, especially in conjunction with treatments that potentiate the apoptotic response ([@bib67]; [@bib105]; [@bib140]; [@bib117]; [@bib123]).

In sum, abnormal mitosis disrupts genome stability through a variety of mechanisms and has the capacity to empower cells with growth advantages that promote the development of cancer. However, abnormal mitosis also imparts specific vulnerabilities. Identifying these weaknesses, as well as novel ways to exploit them, remains a primary objective of future cell biological research.
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